Dr. reddy's laboratories announces the launch of ertapenem for injection in the u.s. market

Hyderabad, india & princeton, n.j.--(business wire)--dr. reddy's laboratories ltd. (bse: 500124, nse: drreddy, nyse: rdy, nseifsc: drreddy, along with its subsidiaries together referred to as “dr. reddy's”) today announced the launch of ertapenem for injection, 1 g/vial, a therapeutic equivalent generic version of invanz (ertapenem for injection) for injection, 1 g/vial approved by the u.s. food and drug administration (usfda). “we are pleased to bring this important product to market at this t
RDY Ratings Summary
RDY Quant Ranking